TN2012000207A1 - Spiropiperidine compounds as orl-1 receptor antagonists - Google Patents

Spiropiperidine compounds as orl-1 receptor antagonists

Info

Publication number
TN2012000207A1
TN2012000207A1 TNP2012000207A TN2012000207A TN2012000207A1 TN 2012000207 A1 TN2012000207 A1 TN 2012000207A1 TN P2012000207 A TNP2012000207 A TN P2012000207A TN 2012000207 A TN2012000207 A TN 2012000207A TN 2012000207 A1 TN2012000207 A1 TN 2012000207A1
Authority
TN
Tunisia
Prior art keywords
orl
treatment
receptor antagonists
compounds
spiropiperidine compounds
Prior art date
Application number
TNP2012000207A
Inventor
Collado Ana Belen Benito
Buezo Nuria Diaz
Aguado Alma Maria Jimenez
Blanco Celia Lafuente
Grau Maria Angeles Martinez
Tercero Conception Pedregal
Escribano Miguel Angel Toledo
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2010/056180 external-priority patent/WO2011060035A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TN2012000207A1 publication Critical patent/TN2012000207A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

As ORL-1 receptor antagonist of the formula I, its uses, and methods for its preparation are described. ORL-1 antagonists are deemed to be useful; in the treatment of depression and/or the treatment of overweight, obesity, and/or weight maintenance post treatment for overweight or obesity. Certain compounds have also demonstrated through animal models that the compounds of the present invention are useful for the treatment of migraine.
TNP2012000207A 2010-01-27 2012-05-08 Spiropiperidine compounds as orl-1 receptor antagonists TN2012000207A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29862910P 2010-01-27 2010-01-27
PCT/US2010/056180 WO2011060035A1 (en) 2009-11-16 2010-11-10 Spiropiperidine compounds as orl-1 receptor antagonists

Publications (1)

Publication Number Publication Date
TN2012000207A1 true TN2012000207A1 (en) 2013-12-12

Family

ID=60997181

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2012000207A TN2012000207A1 (en) 2010-01-27 2012-05-08 Spiropiperidine compounds as orl-1 receptor antagonists

Country Status (1)

Country Link
TN (1) TN2012000207A1 (en)

Similar Documents

Publication Publication Date Title
PT2501704E (en) Spiropiperidine compounds as oral-1 receptor antagagonisten
EA201290352A1 (en) SPYROPYPERIDINE CONNECTIONS AS ANTAGONISTS OF ORL-1 RECEPTOR
MX342161B (en) Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders.
MX352881B (en) Methods and compounds useful in the synthesis of orexin-2 receptor antagonists.
PH12015501289B1 (en) Novel benzimidazole derivatives as ep4 antagonists
MY163055A (en) Polycyclic antagonists of lysophosphatidic acid receptors
EP4374919A3 (en) Methods for treating atopic dermatitis by administering an il-4r antagonist
UA102857C2 (en) Quinuclidine carbonate derivatives and use thereof
GB0906579D0 (en) Pharmaceuticals, compositions and methods of making and using the same
TN2012000126A1 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
MY165113A (en) Piperidinone carboxamide azaindane cgrp receptor antagonists
UA107334C2 (en) Alkaloid aminoester derivatives and their drug compositions
WO2013169574A3 (en) Aliphatic spirolactam cgrp receptor antagonists
PH12014501195A1 (en) Novel 2h-indazoles as ep2, receptor antagonists
EP2552209A4 (en) Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use
MY172809A (en) Spirothienopyran-piperidine derivatives as orl-1 receptor antagonists for their use in the treatment of alcohol dependence and abuse
MX337106B (en) Nicotinic receptor non-competitive antagonists.
TN2012000207A1 (en) Spiropiperidine compounds as orl-1 receptor antagonists
WO2009108635A3 (en) Novel compositions for treatment of diseases related to activated lymphocytes
CL2012001262A1 (en) Spiropiperidine derived compounds; pharmaceutical composition; and use as orl-1 receptor antagonists in the treatment of depression, migraine, obesity.
MX2013007952A (en) Nicotinic receptor non-competitive antagonists.
CY1114664T1 (en) Spiropiperidine Compounds as ORL-1 Competitor Receptors
TN2011000063A1 (en) Quinuclidine carbonate derivatives and medicinal composition thereof
UA96048C2 (en) Use of interleukin-1 receptor antagonist as an frigoprotective agent
UA108500C2 (en) Noncompetitive antagonists of nicotinic receptors